Journal article
Moving towards a population health approach to the primary prevention of common mental disorders
FN Jacka, A Mykletun, M Berk
BMC Medicine | BMC | Published : 2012
Abstract
There is a need for the development of effective universal preventive approaches to the common mental disorders, depression and anxiety, at a population level. Poor diet, physical inactivity and smoking have long been recognized as key contributors to the high prevalence noncommunicable diseases. However, there are now an increasing number of studies suggesting that the same modifiable lifestyle behaviors are also risk factors for common mental disorders. In this paper we point to the emerging data regarding lifestyle risk factors for common mental disorders, with a particular focus on and critique of the newest evidence regarding diet quality. On the basis of this most recent evidence, we c..
View full abstractGrants
Awarded by National Institutes of Health
Funding Acknowledgements
FNJ has received Grant/Research support from the Brain and Behaviour Research Institute (NARSAD), the National Health and Medical Research Council (NHMRC), Australian Rotary Health, the Geelong Medical Research Foundation, the Ian Potter Foundation, Eli Lilly and The University of Melbourne and has been a paid speaker for Sanofi-Synthelabo, Janssen Cilag, Servier, Pfizer, Astra Zeneca, Network Nutrition, Generation Next/Health Ed and Eli Lilly. She is supported by an NHMRC Postdoctoral Training Fellowship (#628912). AM received funding from the Norwegian Research Council for this work. MB has received Grant/Research Support from the National Institutes for Health, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, MBF, the National Health and Medical Research Council, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma and Servier, has been a speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Merck, Pfizer, Sanofi-Synthelabo, Servier, Solvay and Wyeth, and served as a consultant to Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck and Servier. These funding bodies did not play a role in the design or content of this work. The authors wish to thank Dr Sharon Brennan and Ms Shae Quirk for undertaking a systematic review of the diet quality and mental health relationship, some of the results of which informed the narrative review in this commentary.